bpc-157 tga approved australia RACGP BPC-157 + TB-500 (Premium) |

Defining the role of NG2-expressing cells in experimental models of multiple sclerosis: a biofunctional analysis of the neurovascular unit in wild type and NG2 null mice

A major limitation of injectable biologic therapies in sexual medicine is inadequate control of tissue exposure and residence time following administration

Clean energy + targeted recovery

Heavy metal content testing specifically examines lead, arsenic, mercury, and cadmium levels, confirming compliance with international cosmetic safety limits

BPC-157 demonstrates broad cytoprotective properties across multiple organ systems in animal studies, with particular relevance to gastrointestinal and musculoskeletal tissues